Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (LIVN)
NASDAQ:LIVN
LIVN Stock Chart & Stats
$54.45
$0.70(1.49%)
At close: 4:00 PM EST
$54.45
$0.70(1.49%)
Day’s Range― - ―
52-Week Range$32.48 - $58.91
Previous CloseN/A
Volume66.13K
Average Volume (3M)481.28K
Market Cap
$2.99B
Enterprise Value$2.35B
Total Cash (Recent Filing)$593.64M
Total Debt (Recent Filing)$473.40M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Nov 05, 2025EPS Estimate
0.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.05
Shares Outstanding54,601,074
10 Day Avg. Volume361,195
30 Day Avg. Volume481,277
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue1.80
Enterprise Value/Gross Profit2.60
Enterprise Value/Ebitda-32.14
Forecast
1Y Price Target
$63.14Price Target Upside15.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Financial GuidanceLIVN raised its 2025 organic revenue and EPS guidance.
Market PotentialThe obstructive sleep apnea market is large, with an estimated 54 million people in the US affected.
Product ApprovalLIVN has submitted for premarket approval of its aura6000 hypoglossal nerve stimulation device for obstructive sleep apnea.
Bears Say
Competitive PressureLIVN can capture market share from Inspire Medical, which has guided to significant sales growth.
Segment PerformanceBoth LIVN's Cardiopulmonary and Neuromodulation businesses beat consensus with Cardiopulmonary growth slowing and Neuromodulation growth improving.
LivaNova News
LIVN FAQ
What was LivaNova PLC’s price range in the past 12 months?
LivaNova PLC lowest stock price was $32.48 and its highest was $58.91 in the past 12 months.
What is LivaNova PLC’s market cap?
LivaNova PLC’s market cap is $2.99B.
When is LivaNova PLC’s upcoming earnings report date?
LivaNova PLC’s upcoming earnings report date is Nov 05, 2025 which is in 11 days.
How were LivaNova PLC’s earnings last quarter?
LivaNova PLC released its earnings results on Aug 06, 2025. The company reported $1.05 earnings per share for the quarter, beating the consensus estimate of $0.867 by $0.183.
Is LivaNova PLC overvalued?
According to Wall Street analysts LivaNova PLC’s price is currently Undervalued.
Does LivaNova PLC pay dividends?
LivaNova PLC does not currently pay dividends.
What is LivaNova PLC’s EPS estimate?
LivaNova PLC’s EPS estimate is 0.92.
How many shares outstanding does LivaNova PLC have?
LivaNova PLC has 54,601,074 shares outstanding.
What happened to LivaNova PLC’s price movement after its last earnings report?
LivaNova PLC reported an EPS of $1.05 in its last earnings report, beating expectations of $0.867. Following the earnings report the stock price went up 11.148%.
Which hedge fund is a major shareholder of LivaNova PLC?
Currently, no hedge funds are holding shares in LIVN
LivaNova Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$63.14 (15.96% Upside)
$63.14 (15.96% Upside)
Blogger Sentiment
Bullish
LIVN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 119.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $84.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.73%
12-Months-Change
Fundamentals
Return on Equity
-17.87%
Trailing 12-Months
Asset Growth
2.18%
Trailing 12-Months
Company Description
LivaNova PLC
LivaNova (LIVN) is a global medical technology company focused on developing innovative therapies for patients suffering from severe neurological and cardiovascular conditions. The company operates primarily in two sectors: cardiovascular and neuromodulation. LivaNova's core products include advanced cardiac surgery devices, neuromodulation devices for epilepsy treatment, and various other therapeutic solutions aimed at improving patient outcomes and enhancing surgical procedures.
LIVN Company Deck
LIVN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance for LivaNova in the second quarter of 2025, with significant revenue growth, successful clinical milestones, and improved financial health. However, supply chain constraints and an increased tax rate were noted as challenges.View all LIVN earnings summariesLIVN Stock 12 Month Forecast
Average Price Target
$63.14
▲(15.96% Upside)
Technical Analysis
Artivion
―
Integer Holdings
―
Ufp Technologies
―
Inspire Medical Systems
―
TransMedics Group
―
Ownership Overview
0.28% Insiders
29.36% Mutual Funds
0.11% Other Institutional Investors
50.40% Public Companies and
Individual Investors